<?xml version="1.0" encoding="UTF-8"?>
<?xml-stylesheet href="http://feeds.feedburner.com/~d/styles/rss2full.xsl" type="text/xsl" media="screen"?><?xml-stylesheet href="http://feeds.feedburner.com/~d/styles/itemcontent.css" type="text/css" media="screen"?><rss xmlns:feedburner="http://rssnamespace.org/feedburner/ext/1.0" version="2.0">
<channel>
<title>Dr. Tanelian's Top Health News</title>
<link>http://www.healthconnexin.com/hcn1_0/articles/?/news</link>
<description>Important health news.</description>
<image>
<url>http://www.healthconnexin.com/hcn1_0/articles/rss.ashx/news/image</url>
<title>Dr. Tanelian's Top Health News</title>
<link>http://www.healthconnexin.com/hcn1_0/articles/?/news</link>
</image>

<atom10:link xmlns:atom10="http://www.w3.org/2005/Atom" rel="self" href="http://feeds.feedburner.com/DrTanelianHealthNews" type="application/rss+xml" /><feedburner:browserFriendly></feedburner:browserFriendly><item>
<title>Vitamin D Deficiency Linked to Breast Cancer</title>
<description>Researchers from The Fred Hutchinson Cancer Research Center, Univ. of South Carolina, the National Cancer Institute, UCLA, Univ. of Souther California, Univ. of New Mexico and the Univ. of Louisville published a study linking vitamin D insufficiency to breast cancer in this months American Journal of Clinical Nutrition.790 breast cancer survivors were studied.&amp;nbsp; 579 (75.6%) of the women had low serum 25(OH)D suggesting vitamin D insufficiency.&amp;nbsp; Cancer treatments showed that the stage of disease was independently predicted by te serum 25(OH)D (vitamin D) level.Referenced Study</description>
<link>http://www.healthconnexin.com/hcn1_0/articles/?/news/15361e69-6d92-4fa1-a7cd-6eacbc3ed3d0</link>
<pubDate>Thu, 10 Jul 2008 00:00:00 GMT</pubDate>
</item>

<item>
<title>Low Vitamin D Levels Associated with Mortality</title>
<description>&amp;nbsp;The Achives of Internal Medicine published a study from the Medical University in Graz, Austria that shows low Vitamin D (25-hydroxy D and 1,25-dihydroxyvitamin D) to be associated with increased All-Cause and Cardiovascular Mortality.Referenced Study</description>
<link>http://www.healthconnexin.com/hcn1_0/articles/?/news/96570847-6949-40c0-b55d-24842e0118b1</link>
<pubDate>Thu, 10 Jul 2008 00:00:00 GMT</pubDate>
</item>

<item>
<title>Beware of  Excess Vitamin C </title>
<description>&amp;nbsp;A report from the Department of Medicine at the University of Oaklahoma Health Science Center describes how a large dose of vitamin C (680 mg) led to Calcium Oxalate- induced nepthropathy (Kidney Failure).This could be you - so don't injust excessive (more than 400 mg/d) of vitamin C for no reason.Vitamin C once metabolized is metabolically converted to Oxalate which can result in Kidney stones.Referenced Study</description>
<link>http://www.healthconnexin.com/hcn1_0/articles/?/news/e3562edf-3e66-4271-b224-7872f138824f</link>
<pubDate>Thu, 10 Jul 2008 00:00:00 GMT</pubDate>
</item>

<item>
<title>Low Vitamin D Associated with Increased Risk of Heart Disease</title>
<description>&amp;nbsp;Researchers at the University of Hong Kong published a study in The American Journal of Clinical Nutrition which identified that an increase in serum vitamin D (25(OH)D was associated with a reduction of cardiovascular events, 44% reduction per 1 unit incrase in serum 25 (OH)D.Referenced Study</description>
<link>http://www.healthconnexin.com/hcn1_0/articles/?/news/e8a7cac8-3cb4-416e-a855-2640576e29b3</link>
<pubDate>Thu, 10 Jul 2008 00:00:00 GMT</pubDate>
</item>

<item>
<title>Vitamin D intake required for desired blood levels</title>
<description>The American Journal of Clinical Nutrition published a study from the Bone Research Center at Winthrop University in New York that determined the amount of Vitamin D needed to supplement daily to acheive an optimal daily range of 72-220 nmol/L is 115ug/d (4600IU).&amp;nbsp; No hypercalcemia or hypercalciuria was observed.Referenced Study</description>
<link>http://www.healthconnexin.com/hcn1_0/articles/?/news/3805b55c-ac21-4bf6-84c4-5f11e1584941</link>
<pubDate>Thu, 10 Jul 2008 00:00:00 GMT</pubDate>
</item>

<item>
<title>Growth Hormone Review Does Not Support Enhancement of Athletic Performance</title>
<description>&amp;nbsp;The Annals of Internal Medicine published a review fo 44 controlled studies of growth hormone treatment of individuals aged 13 to 45 years old, representing 13.3 person-years of treatment.&amp;nbsp; The research was from Stanford University, Santo Clara Valley Medical Center and Veterans Affairs Palo Alto Health Care System.&amp;nbsp; Claims that growth hormone enhances physical performance were not supported by the scientific literature.&amp;nbsp; Strengh and exercise capacity were not improved by growth hormone.&amp;nbsp; Lactate levels during exercise were higher and growth-hormone treated participants more frequently experienced soft tissue swelling and fatigue.Referenced Study</description>
<link>http://www.healthconnexin.com/hcn1_0/articles/?/news/eb4f63cf-77a3-4a7c-a740-3abff83cd2a9</link>
<pubDate>Wed, 21 May 2008 00:00:00 GMT</pubDate>
</item>

</channel>
</rss>
